These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1925 related articles for article (PubMed ID: 30376874)
21. The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma. Ahmadov U; Picard D; Bartl J; Silginer M; Trajkovic-Arsic M; Qin N; Blümel L; Wolter M; Lim JKM; Pauck D; Winkelkotte AM; Melcher M; Langini M; Marquardt V; Sander F; Stefanski A; Steltgens S; Hassiepen C; Kaufhold A; Meyer FD; Seibt A; Kleinesudeik L; Hain A; Münk C; Knobbe-Thomsen CB; Schramm A; Fischer U; Leprivier G; Stühler K; Fulda S; Siveke JT; Distelmaier F; Borkhardt A; Weller M; Roth P; Reifenberger G; Remke M Cell Death Dis; 2021 Sep; 12(10):885. PubMed ID: 34584066 [TBL] [Abstract][Full Text] [Related]
22. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996 [TBL] [Abstract][Full Text] [Related]
23. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion. Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788 [TBL] [Abstract][Full Text] [Related]
24. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme. Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD Gene; 2020 Jan; 723():144126. PubMed ID: 31589963 [TBL] [Abstract][Full Text] [Related]
25. Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells. Zhao J; Jin W; Yi K; Wang Q; Zhou J; Tan Y; Xu C; Xiao M; Hong B; Xu F; Zhang K; Kang C Pharmacol Res; 2021 Sep; 171():105764. PubMed ID: 34246782 [TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression. Xia H; Liu Y; Wang Z; Zhang W; Qi M; Qi B; Jiang X Neurotherapeutics; 2020 Apr; 17(2):754-764. PubMed ID: 31691127 [TBL] [Abstract][Full Text] [Related]
27. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559 [TBL] [Abstract][Full Text] [Related]
28. Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation. Wang XQ; Dostie J Nucleic Acids Res; 2017 Feb; 45(3):1091-1104. PubMed ID: 28180285 [TBL] [Abstract][Full Text] [Related]
29. lncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop. Li F; Xu Y; Xu X; Ge S; Zhang F; Zhang H; Fan X Mol Ther Nucleic Acids; 2020 Dec; 22():456-470. PubMed ID: 33230449 [TBL] [Abstract][Full Text] [Related]
30. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1. Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150 [TBL] [Abstract][Full Text] [Related]
31. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis. Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715 [TBL] [Abstract][Full Text] [Related]
32. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
33. Up-regulation of DNMT3b contributes to HOTAIRM1 silencing via DNA hypermethylation in cells transformed by long-term exposure to hydroquinone and workers exposed to benzene. Zhang H; Yuan Q; Pan Z; Ling X; Tan Q; Wu M; Zheng D; Xie P; Xie D; Liu L Toxicol Lett; 2020 Apr; 322():12-19. PubMed ID: 31899212 [TBL] [Abstract][Full Text] [Related]
34. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p. Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942 [TBL] [Abstract][Full Text] [Related]
35. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells. Xu C; He T; Li Z; Liu H; Ding B Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213 [TBL] [Abstract][Full Text] [Related]
36. The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells. Kim CY; Oh JH; Lee JY; Kim MH J Cancer; 2020; 11(12):3416-3423. PubMed ID: 32284737 [TBL] [Abstract][Full Text] [Related]
37. lncRNA HOTAIRM1 promotes osteogenesis of hDFSCs by epigenetically regulating HOXA2 via DNMT1 in vitro. Chen Z; Zheng J; Hong H; Chen D; Deng L; Zhang X; Ling J; Wu L J Cell Physiol; 2020 Nov; 235(11):8507-8519. PubMed ID: 32324272 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
39. PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration. Wang J; Shen S; You J; Wang Z; Li Y; Chen Y; Tuo Y; Chen D; Yu H; Zhang J; Wang F; Pang X; Xiao Z; Lan Q; Wang Y Cell Death Dis; 2024 Jul; 15(7):524. PubMed ID: 39043634 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]